Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UMLS:C0038002 (
splenomegaly
)
9,873
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
Common variable immunodeficiency (CVID) is a heterogeneous syndrome characterized by defective immunoglobulin production and high frequency of bacterial infections, autoimmunity and manifestations of chronic inflammation. The
urokinase plasminogen activator
(
uPA
), its cell bound and soluble receptor (uPAR, suPAR) have complex biological functions involving innate immune defense mechanisms and regulation of inflammation. Based on this dual role, we hypothesized that the
uPA
system could be affected in CVID, and examined expression of components of the
uPA
system in subgroups of CVID. All CVID-patients had increased plasma levels of suPAR with particularly high levels in those with
splenomegaly
and thrombocytopenia. Plasma
uPA
levels were also raised in these patients, and both suPAR and
uPA
levels correlated with the monocyte activation marker neopterin. Monocytes from CVID patients had increased expression of uPAR. We show an increased activation of the
uPA
system possibly contributing to the inflammatory phenotype seen in subgroups of CVID patients.
...
PMID:Enhanced levels of urokinase plasminogen activator and its soluble receptor in common variable immunodeficiency. 1923 8